These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2560981)

  • 1. The use of mu opioid receptors in the mouse vas deferens for the study of opiate tolerance.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1989 Dec; 174(2-3):267-71. PubMed ID: 2560981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.
    James MK; Feldman PL; Schuster SV; Bilotta JM; Brackeen MF; Leighton HJ
    J Pharmacol Exp Ther; 1991 Nov; 259(2):712-8. PubMed ID: 1658308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid receptor selectivity for trimebutine in isolated tissues experiments and receptor binding studies.
    Kaneto H; Takahashi M; Watanabe J
    J Pharmacobiodyn; 1990 Jul; 13(7):448-53. PubMed ID: 1963196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of opioid receptor ligands on the mu-S196A knock-in and mu knockout mouse vas deferens.
    Portoghese PS; Law PY; Loh HH
    Eur J Pharmacol; 2003 Oct; 478(2-3):207-10. PubMed ID: 14575806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of meptazinol and its enantiomers on guinea-pig ileum and mouse vas deferens.
    Duchesne RJ; Goodall J; Hughes IE
    J Pharm Pharmacol; 1984 Aug; 36(8):560-2. PubMed ID: 6148406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loperamide: evidence of interaction with mu and delta opioid receptors.
    Giagnoni G; Casiraghi L; Senini R; Revel L; Parolaro D; Sala M; Gori E
    Life Sci; 1983; 33 Suppl 1():315-8. PubMed ID: 6319884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
    Elliott J; Traynor JR
    Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
    Porreca F; LoPresti D; Ward SJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate receptor binding studies in the mouse vas deferens exhibiting tolerance without dependence.
    Rubini P; Schulz R; Wüster M; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):142-6. PubMed ID: 6287304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey.
    Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA
    Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity between mu-opioid receptors in mouse vas deferens and guinea-pig ileum.
    Goodall J; Hughes IE; Mackay D
    Br J Pharmacol; 1985 May; 85(1):277-83. PubMed ID: 2992651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choice of opioid receptor subtype in isolated preparations by ohmefentanyl.
    Jin WQ; Chen XJ; Chi ZQ
    Sci Sin B; 1987 Feb; 30(2):176-81. PubMed ID: 3039656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
    Hayes AG; Sheehan MJ; Tyers MB
    Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone elicits an excitatory response in the morphine-tolerant mouse vas deferens.
    Vargas ML; Musacchio JM; Bansinath M; Turndorf H; Puig MM
    Neuropharmacology; 1987 Dec; 26(12):1815-8. PubMed ID: 3437943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference between mu-receptors in the guinea pig ileum and the mouse vas deferens.
    Sayre LM; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1983 May; 90(1):159-60. PubMed ID: 6307720
    [No Abstract]   [Full Text] [Related]  

  • 18. The development of opiate tolerance may dissociate from dependence.
    Wüster M; Schulz R; Herz A
    Life Sci; 1982 Oct 18-25; 31(16-17):1695-8. PubMed ID: 6891426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supersensitivity to morphine of the transmurally stimulated vas deferens isolated from ethanol-pretreated mice.
    Tabach R; De Moraes S
    Eur J Pharmacol; 1992 Jun; 216(3):449-51. PubMed ID: 1330584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proglumide exhibits delta opioid agonist properties.
    Rezvani A; Stokes KB; Rhoads DL; Way EL
    Alcohol Drug Res; 1987; 7(3):135-46. PubMed ID: 3030338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.